Fibroblast growth factor 21 variant, composition , and uses thereof
US9422353B2 · kind B2 · utility
2Cited by
4References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2013 |
| Grant date | Aug 23, 2016 |
| Priority date | — |
| Expiry date | Jun 5, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This present invention relates to pharmacologically potent and stable human fibroblast growth factor 21 (FGF21) variants, pharmaceutical compositions comprising FGF21 variants, and methods for treating type 2 diabetes, obesity, dyslipidemia, and/or metabolic syndrome using such variants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.